← All companies

WST

West Pharmaceutical Services, Inc.

WST NYSE Surgical & Medical Instruments & Apparatus EDGAR ↗

$347.94

+8.35 +2.46%

Key statistics

from XBRL data in SEC filings

Market cap

$24.5B

Revenue (TTM)

$3.33B

Net income (TTM)

$565M

EPS (TTM)

$7.81

P/E ratio

44.6

Dividend yield

0.25%

Free cash flow

$469M

Cash

$436M

Total assets

$4.08B

Gross margin

36.8%

52-week range

$223.83 – $386.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 23, 2026 8-K Entered a material agreement Jul 14, 2026 8-K Director or officer change; Regulation FD disclosure Jun 1, 2026 8-K/A Item 1.05 May 20, 2026 8-K Item 1.05; Regulation FD disclosure May 11, 2026 8-K Shareholder vote results May 5, 2026 10-Q Quarter ended 2026-03-31 Apr 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 23, 2026 8-K Director or officer change; Regulation FD disclosure Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 12, 2026 10-Q Quarter ended 2025-09-30 Oct 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 23, 2025 8-K Director or officer change Sep 11, 2025 10-Q Quarter ended 2025-06-30 Jul 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 24, 2025 8-K Director or officer change Jul 21, 2025 8-K/A Director or officer change May 12, 2025 8-K Shareholder vote results May 8, 2025 10-Q Quarter ended 2025-03-31 Apr 24, 2025 8-K Director or officer change Apr 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 24, 2025 8-K Director or officer change Apr 14, 2025 8-K Director or officer change Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 13, 2025 8-K Other events Dec 13, 2024 8-K Director or officer change; Regulation FD disclosure Dec 11, 2024 10-Q Quarter ended 2024-09-30 Oct 24, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 24, 2024 8-K Director or officer change Oct 7, 2024 10-Q Quarter ended 2024-06-30 Jul 25, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 25, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 8, 2024 8-K Director or officer change; Shareholder vote results Apr 26, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 25, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 15, 2024